Nuzenio

Keytruda

Keytruda news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Alteogen returns to profit as Keytruda SC sales and platform deals surge - CHOSUNBIZ - ChosunbizChosunbiz · Fri, 07 Aug 2026 02:00:00 GMT Unpacking Subgroup Data With First-Line Ipatasertib Plus Pembrolizumab in HNSCC - OncLiveOncLive · Thu, 06 Aug 2026 22:53:51 GMT FDA Clears Trodelvy as First-Line Therapy for TNBC - Clinical Oncology NewsClinical Oncology News · Thu, 06 Aug 2026 19:42:10 GMT How Stronger 2026 Guidance And New Drug Indications At Merck (MRK) Has Changed Its Investment Story - simplywall.stsimplywall.st · Thu, 06 Aug 2026 13:35:36 GMT MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMT Summit expands ivonescimab's challenge to Keytruda into bladder cancer - AllSciAllSci · Thu, 06 Aug 2026 09:59:29 GMT Health Canada Approves KEYTRUDA® for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 15:00:00 GMT Merck CEO says new pipeline is built to offset Keytruda's eventual patent expiration - CNBCCNBC · Tue, 04 Aug 2026 23:14:25 GMT

Timeline

Fri, 07 Aug 2026 02:00:00 GMTAlteogen returns to profit as Keytruda SC sales and platform deals surge - CHOSUNBIZ - Chosunbiz

Thu, 06 Aug 2026 22:53:51 GMTUnpacking Subgroup Data With First-Line Ipatasertib Plus Pembrolizumab in HNSCC - OncLive

Thu, 06 Aug 2026 19:42:10 GMTFDA Clears Trodelvy as First-Line Therapy for TNBC - Clinical Oncology News

Thu, 06 Aug 2026 13:35:36 GMTHow Stronger 2026 Guidance And New Drug Indications At Merck (MRK) Has Changed Its Investment Story - simplywall.st

Thu, 06 Aug 2026 10:25:17 GMTMSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data - Clinical Trials Arena

Thu, 06 Aug 2026 09:59:29 GMTSummit expands ivonescimab's challenge to Keytruda into bladder cancer - AllSci

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Merck5 live mentions MRK4 live mentions Clinical Trials Arena3 live mentions Keytruda SC2 live mentions Line Ipatasertib Plus2 live mentions Pembrolizumab2 live mentions FDA Clears Trodelvy2 live mentions First2 live mentions Line Therapy2 live mentions How Stronger2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Keytruda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.